The Complex Diseases of in Canines: Where to Next?

Overview

Journal Vet Sci

Publisher MDPI

Specialty Veterinary Medicine

Date 2021 Jan 22

PMID 33477504

Citations 43

Authors

Stephanie A Lynch

Karla J Helbig

Affiliations

Soon will be listed here.

Abstract

is a pathogenic bacterium of concern within the veterinary sector and is involved in numerous infections in canines, including topical infections such as canine pyoderma and otitis externa, as well as systemic infections within the urinary, respiratory and reproductive tract. The high prevalence of methicillin-resistant (MRSP) within such infections is a growing concern. Therefore, it is crucial to understand the involvement of in canine disease pathology to gain better insight into novel treatment avenues. Here, we review the literature focused on infection in multiple anatomic locations in dogs and the role of MRSP in treatment outcomes at these niches. Multiple novel treatment avenues for MRSP have been pioneered in recent years and these are discussed with a specific focus on vaccines and phage therapy as potential therapeutic options. Whilst both undertakings are in their infancy, phage therapy is versatile and has shown high success in both animal and human medical use. It is clear that further research is required to combat the growing problems associated with MRSP in canines.

Citing Articles

Comparison of Isolated from Human Clinical Cases and Cat Carriers Regarding Antibiotic Susceptibility and Biofilm Production.

Bierowiec K, Delmar A, Karwanska M, Siedlecka M, Kumala-Cwikla A, Ksiazczyk M Int J Mol Sci. 2025; 26(5).

PMID: 40076573 PMC: 11900592. DOI: 10.3390/ijms26051948.

In vitro characterization of potential botanicals to reduce infection and improve the rate of wound healing in humans and canines.

Detering M, Langland A, Terry A, Langland J BMC Complement Med Ther. 2025; 25(1):55.

PMID: 39953529 PMC: 11829538. DOI: 10.1186/s12906-025-04777-2.

Surveillance of antimicrobial resistance in hospitalized companion animals in China in 2022-23.

Liu Y, Zhai Y, Jiang C, Liu H, Li Z, Yuan Y JAC Antimicrob Resist. 2025; 7(1):dlaf007.

PMID: 39877078 PMC: 11772556. DOI: 10.1093/jacamr/dlaf007.

Antimicrobial Prescribing Practices Among Sri Lankan Veterinarians for Common Medical Conditions in Companion Animals.

De Silva L, Wijayawardhane N, Kalupahana R, Kottawatta K, Pushpakumara P, Riley C Animals (Basel). 2025; 15(1.

PMID: 39795012 PMC: 11718978. DOI: 10.3390/ani15010069.

Pharmacokinetics and Pharmacodynamics Evaluation of Amoxicillin Against in Dogs.

Jeong J, Kim J, Kim J, Kim C, Chung E, Boo S Pathogens. 2025; 13(12.

PMID: 39770380 PMC: 11679838. DOI: 10.3390/pathogens13121121.

References

Shimizu A, Berkhoff H, Kloos W, George C, Ballard D . Genomic DNA fingerprinting, using pulsed-field gel electrophoresis, of Staphylococcus intermedius isolated from dogs. Am J Vet Res. 1996; 57(10):1458-62. View

Lyskova P, Vydrzalova M, Mazurova J . Identification and antimicrobial susceptibility of bacteria and yeasts isolated from healthy dogs and dogs with otitis externa. J Vet Med A Physiol Pathol Clin Med. 2007; 54(10):559-63. DOI: 10.1111/j.1439-0442.2007.00996.x. View

Abouelkhair M, Bemis D, Kania S . Characterization of recombinant wild-type and nontoxigenic protein A from Staphylococcus pseudintermedius. Virulence. 2018; 9(1):1050-1061. PMC: 6086296. DOI: 10.1080/21505594.2018.1489199. View

Bugden D . Identification and antibiotic susceptibility of bacterial isolates from dogs with otitis externa in Australia. Aust Vet J. 2013; 91(1-2):43-6. DOI: 10.1111/avj.12007. View

Perry L, MacLennan B, Korven R, Rawlings T . Epidemiological study of dogs with otitis externa in Cape Breton, Nova Scotia. Can Vet J. 2017; 58(2):168-174. PMC: 5234316. View

Huerta B, Maldonado A, Ginel P, Tarradas C, Gomez-Gascon L, Astorga R . Risk factors associated with the antimicrobial resistance of staphylococci in canine pyoderma. Vet Microbiol. 2011; 150(3-4):302-8. DOI: 10.1016/j.vetmic.2011.02.002. View

Thammavongsa V, Kim H, Missiakas D, Schneewind O . Staphylococcal manipulation of host immune responses. Nat Rev Microbiol. 2015; 13(9):529-43. PMC: 4625792. DOI: 10.1038/nrmicro3521. View

DeBoer D, Moriello K, Thomas C, Schultz K . Evaluation of a commercial staphylococcal bacterin for management of idiopathic recurrent superficial pyoderma in dogs. Am J Vet Res. 1990; 51(4):636-9. View

Pilla R, Bonura C, Malvisi M, Snel G, Piccinini R . Methicillin-resistant Staphylococcus pseudintermedius as causative agent of dairy cow mastitis. Vet Rec. 2013; 173(1):19. DOI: 10.1136/vr.101485. View

10.

Hagman R . Pyometra in Small Animals. Vet Clin North Am Small Anim Pract. 2018; 48(4):639-661. DOI: 10.1016/j.cvsm.2018.03.001. View

11.

Yoo J, Yoon J, Lee S, Park H . High prevalence of Fluoroquinolone- and Methicillin-resistant Staphylococcus pseudintermedius isolates from canine pyoderma and otitis externa in veterinary teaching hospital. J Microbiol Biotechnol. 2010; 20(4):798-802. View

12.

Chan W, Hickey E, Khazandi M, Page S, Trott D, Hill P . In vitro antimicrobial activity of narasin against common clinical isolates associated with canine otitis externa. Vet Dermatol. 2018; 29(2):149-e57. DOI: 10.1111/vde.12516. View

13.

Meloni T, Martino P, Grieco V, Pisu M, Banco B, Rota A . A survey on bacterial involvement in neonatal mortality in dogs. Vet Ital. 2014; 50(4):293-9. DOI: 10.12834/VetIt.45.2244.2. View

14.

Malik D, Sokolov I, Vinner G, Mancuso F, Cinquerrui S, Vladisavljevic G . Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interface Sci. 2017; 249:100-133. DOI: 10.1016/j.cis.2017.05.014. View

15.

Kloos I, Straubinger R, Werckenthin C, Mueller R . Residual antibacterial activity of dog hairs after therapy with antimicrobial shampoos. Vet Dermatol. 2013; 24(2):250-e54. DOI: 10.1111/vde.12012. View

16.

Ngo J, Taminiau B, Fall P, Daube G, Fontaine J . Ear canal microbiota - a comparison between healthy dogs and atopic dogs without clinical signs of otitis externa. Vet Dermatol. 2018; 29(5):425-e140. DOI: 10.1111/vde.12674. View

17.

HOEKSTRA K, Paulton R . Clinical prevalence and antimicrobial susceptibility of Staphylococcus aureus and Staph. intermedius in dogs. J Appl Microbiol. 2002; 93(3):406-13. DOI: 10.1046/j.1365-2672.2002.01708.x. View

18.

van Duijkeren E, Kamphuis M, van der Mije I, Laarhoven L, Duim B, Wagenaar J . Transmission of methicillin-resistant Staphylococcus pseudintermedius between infected dogs and cats and contact pets, humans and the environment in households and veterinary clinics. Vet Microbiol. 2011; 150(3-4):338-43. DOI: 10.1016/j.vetmic.2011.02.012. View

19.

Ramos S, Woodward M, Hoppers S, Liu C, Pucheu-Haston C, Mitchell M . Residual antibacterial activity of canine hair treated with five mousse products against Staphylococcus pseudintermedius in vitro. Vet Dermatol. 2019; 30(3):183-e57. DOI: 10.1111/vde.12737. View

20.

Lappin M, Blondeau J, Boothe D, Breitschwerdt E, Guardabassi L, Lloyd D . Antimicrobial use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases. J Vet Intern Med. 2017; 31(2):279-294. PMC: 5354050. DOI: 10.1111/jvim.14627. View